Status:
COMPLETED
Clinical Evaluation of the RAVI-Guide
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Retinal Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections Aims: To compare patient acceptance and procedural complication rate...
Eligibility Criteria
Inclusion
- Patients age 18 years or older who undergo intravitreal injection for clinical indications.
Exclusion
- Patients under the age of 18 years
- Patients unable to give informed consent
- Disorders that preclude the ability to judge pain or discomfort associated with intravitreal injection
- Disorders that preclude the ability to assess for complications of intravitreal injection
- Inability to assess the landmarks by which localization of intravitreal injection sites is determined, such as obscured corneal limbus
- Inability to communicate directly to the physician and immediately after the procedure the level of pain or discomfort
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT02196584
Start Date
August 1 2014
End Date
June 1 2016
Last Update
June 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert and Medical College of Wisconsin Eye Institute
Milwaukee, Wisconsin, United States, 53226